4D Molecular Therapeutics, Inc. (FDMT)
14.67
-0.24
(-1.61%)
USD |
NASDAQ |
Aug 28, 16:00
14.66
-0.01
(-0.07%)
After-Hours: 17:17
4D Molecular Therapeutics Market Cap : 809.99M for Aug. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 27, 2026 | 823.24M |
| August 26, 2026 | 859.13M |
| August 25, 2026 | 867.97M |
| August 24, 2026 | 849.74M |
| August 21, 2026 | 874.04M |
| August 20, 2026 | 888.95M |
| August 19, 2026 | 925.39M |
| August 18, 2026 | 812.75M |
| August 17, 2026 | 803.09M |
| August 14, 2026 | 673.06M |
| August 13, 2026 | 643.24M |
| August 12, 2026 | 655.39M |
| August 11, 2026 | 633.31M |
| August 10, 2026 | 582.31M |
| August 07, 2026 | 561.92M |
| August 06, 2026 | 551.47M |
| August 05, 2026 | 537.35M |
| August 04, 2026 | 536.31M |
| August 03, 2026 | 527.42M |
| July 31, 2026 | 532.12M |
| July 30, 2026 | 526.38M |
| July 29, 2026 | 502.33M |
| July 28, 2026 | 514.88M |
| July 27, 2026 | 542.58M |
| July 24, 2026 | 526.38M |
| Date | Value |
|---|---|
| July 23, 2026 | 542.58M |
| July 22, 2026 | 572.90M |
| July 21, 2026 | 594.59M |
| July 20, 2026 | 579.69M |
| July 17, 2026 | 574.46M |
| July 16, 2026 | 566.62M |
| July 15, 2026 | 610.53M |
| July 14, 2026 | 611.58M |
| July 13, 2026 | 590.67M |
| July 10, 2026 | 643.46M |
| July 09, 2026 | 673.78M |
| July 08, 2026 | 680.58M |
| July 07, 2026 | 670.12M |
| July 06, 2026 | 664.89M |
| July 02, 2026 | 679.53M |
| July 01, 2026 | 663.33M |
| June 30, 2026 | 695.21M |
| June 29, 2026 | 673.26M |
| June 26, 2026 | 606.35M |
| June 25, 2026 | 602.17M |
| June 24, 2026 | 607.40M |
| June 23, 2026 | 606.35M |
| June 22, 2026 | 544.67M |
| June 18, 2026 | 504.94M |
| June 17, 2026 | 492.40M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 233.72B |
| AnaptysBio, Inc. | 1.631B |
| Precision BioSciences, Inc. | 206.18M |
| Design Therapeutics, Inc. | 944.96M |
| Inhibrx Biosciences, Inc. | 1.814B |
Market Cap Related Metrics
| PS Ratio | 10.05 |
| Price to Book Value | 1.987 |
| Price | 14.67 |
| Earnings Yield | -18.57% |